{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:18:19Z","timestamp":1783138699614,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Department of Science and Technology of Guangdong Province","doi-asserted-by":"publisher","award":["2021B0909050003"],"award-info":[{"award-number":["2021B0909050003"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152331","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:03:34Z","timestamp":1777590214000},"page":"152331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LILRB2+ monocytes reshape the immune activation landscape in immunotherapy with non-small cell lung cancer: Evidence from real-world cohorts and single-cell analyses"],"prefix":"10.1016","volume":"365","author":[{"given":"Linfeng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhuo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152331_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0015","first-page":"1","article-title":"The interplay between MicroRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung Cancer (NSCLC) progression","volume":"2019","author":"Lee","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1470-2045(23)00329-7","article-title":"First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial","volume":"24","author":"\u00d6zg\u00fcro\u011flu","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0025","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/s41591-022-01977-y","article-title":"Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial","volume":"28","author":"Gogishvili","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2021.10.012","volume":"23","author":"Shiraishi","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-024-00932-9","article-title":"Tumour mutational burden: clinical utility, challenges and emerging improvements","volume":"21","author":"Budczies","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2546684","article-title":"Comprehensive analysis of the leukocyte immunoglobulin-like receptor family in clear cell renal cell carcinoma","volume":"57","author":"He","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2009.03097.x","article-title":"Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells","volume":"127","author":"Anderson","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0055","article-title":"LILRB2\/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pccm.2022.11.001","article-title":"Targeting tumor microenvironment for non-small cell lung cancer immunotherapy","volume":"1","author":"Wang","year":"2023","journal-title":"Chinese Medical Journal Pulmonary and Critical Care Medicine."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116087","article-title":"Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML","volume":"44","author":"Zheng","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0070","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151553","article-title":"Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy","volume":"7","author":"De Louche","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-024-00705-7","article-title":"The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications","volume":"12","author":"Hodges","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical landscape of macrophage-reprogramming cancer immunotherapies","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010012","article-title":"LILRB2 blockade facilitates macrophage repolarization and enhances T cell-mediated antitumor immunity","volume":"13","author":"Jones","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-08102-0","article-title":"S100A9 enhances tumor immune suppression and cancer cell survival in small cell lung cancer","volume":"16","author":"Charan","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-01936-w","article-title":"Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma","volume":"23","author":"Kim","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3736","article-title":"Single-cell RNA sequencing reveals microenvironmental infiltration in non-small cell lung cancer with different responses to immunotherapy","volume":"26","author":"Hu","year":"2024","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0105","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00011-024-01871-y","article-title":"Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma","volume":"73","author":"Zhang","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.09.479","article-title":"P2.11B.03 circulating hallmarks of Hyperprogression in NSCLC upon 1st line PD-(L)1 inhibitors alone or in combination with chemotherapy","volume":"19","author":"Ferrara","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0115","first-page":"505","article-title":"Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology","volume":"3","author":"Chu","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types","volume":"26","author":"Monaco","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.07.006","article-title":"Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes","volume":"40","author":"Zaitsev","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell\u2013cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-pathmechdis-012418-013058","article-title":"Monocytes in the tumor microenvironment","volume":"16","author":"Ugel","year":"2021","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0145","article-title":"Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.11.003","article-title":"High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint Cancer therapy","volume":"175","author":"Gubin","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0170","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/s12276-025-01552-8","article-title":"S100A8\/9-NLRP3-mediated chronic unresolved inflammation drives cardiac pathologies following invasive pneumococcal disease","volume":"57","author":"Tousif","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012127","article-title":"Myeloid metabolism and its role in immunotherapy of cancer","volume":"13","author":"Garlatti","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01395","article-title":"Innate immune defense mechanisms by myeloid cells that hamper Cancer immunotherapy","volume":"11","author":"Lebegge","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152331_bb0190","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:42:29Z","timestamp":1783136549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026022580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S0141813026022580"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152331","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LILRB2+ monocytes reshape the immune activation landscape in immunotherapy with non-small cell lung cancer: Evidence from real-world cohorts and single-cell analyses","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152331"}}